Increased Hypothalamic Anti-Inflammatory Mediators in Non-Diabetic Insulin Receptor Substrate 2-Deficient Mice
Insulin receptor substrate (IRS) 2 is a key mediator of insulin signaling and IRS-2 knockout (IRS2<sup>−/−</sup>) mice are a preclinical model to study the development of diabetes, as they develop peripheral insulin resistance and beta-cell failure. The differential inflammatory profile...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/8/2085 |
id |
doaj-d46ff4296d1f473da67f9a2adc2ddc10 |
---|---|
record_format |
Article |
spelling |
doaj-d46ff4296d1f473da67f9a2adc2ddc102021-08-26T13:37:37ZengMDPI AGCells2073-44092021-08-01102085208510.3390/cells10082085Increased Hypothalamic Anti-Inflammatory Mediators in Non-Diabetic Insulin Receptor Substrate 2-Deficient MiceMaría Vinaixa0Sandra Canelles1África González-Murillo2Vítor Ferreira3Diana Grajales4Santiago Guerra-Cantera5Ana Campillo-Calatayud6Manuel Ramírez-Orellana7Óscar Yanes8Laura M. Frago9Ángela M. Valverde10Vicente Barrios11Metabolomics Platform, IISPV, Department of Electronic Engineering (DEEEA), Universitat Rovira i Virgili, E-43002 Tarragona, SpainDepartment of Endocrinology, Hospital Infantil Universitario Niño Jesús, Instituto de Investigación La Princesa, E-28009 Madrid, SpainUnidad de Terapias Avanzadas, Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús, Instituto de Investigación La Princesa, E-28009 Madrid, SpainCIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, E-28029 Madrid, SpainCIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, E-28029 Madrid, SpainDepartment of Endocrinology, Hospital Infantil Universitario Niño Jesús, Instituto de Investigación La Princesa, E-28009 Madrid, SpainDepartment of Endocrinology, Hospital Infantil Universitario Niño Jesús, Instituto de Investigación La Princesa, E-28009 Madrid, SpainUnidad de Terapias Avanzadas, Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús, Instituto de Investigación La Princesa, E-28009 Madrid, SpainMetabolomics Platform, IISPV, Department of Electronic Engineering (DEEEA), Universitat Rovira i Virgili, E-43002 Tarragona, SpainDepartment of Endocrinology, Hospital Infantil Universitario Niño Jesús, Instituto de Investigación La Princesa, E-28009 Madrid, SpainCIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, E-28029 Madrid, SpainDepartment of Endocrinology, Hospital Infantil Universitario Niño Jesús, Instituto de Investigación La Princesa, E-28009 Madrid, SpainInsulin receptor substrate (IRS) 2 is a key mediator of insulin signaling and IRS-2 knockout (IRS2<sup>−/−</sup>) mice are a preclinical model to study the development of diabetes, as they develop peripheral insulin resistance and beta-cell failure. The differential inflammatory profile and insulin signaling in the hypothalamus of non-diabetic (ND) and diabetic (D) IRS2<sup>−/−</sup> mice might be implicated in the onset of diabetes. Because the lipid profile is related to changes in inflammation and insulin sensitivity, we analyzed whether ND IRS2<sup>−/−</sup> mice presented a different hypothalamic fatty acid metabolism and lipid pattern than D IRS2<sup>−/−</sup> mice and the relationship with inflammation and markers of insulin sensitivity. ND IRS2<sup>−/−</sup> mice showed elevated hypothalamic anti-inflammatory cytokines, while D IRS2<sup>−/−</sup> mice displayed a proinflammatory profile. The increased activity of enzymes related to the pentose-phosphate route and lipid anabolism and elevated polyunsaturated fatty acid levels were found in the hypothalamus of ND IRS2<sup>−/−</sup> mice. Conversely, D IRS2<sup>−/−</sup> mice have no changes in fatty acid composition, but hypothalamic energy balance and markers related to anti-inflammatory and insulin-sensitizing properties were reduced. The data suggest that the concurrence of an anti-inflammatory profile, increased insulin sensitivity and polyunsaturated fatty acids content in the hypothalamus may slow down or delay the onset of diabetes.https://www.mdpi.com/2073-4409/10/8/2085diabeteshypothalamusinflammationIRS2<sup>−/−</sup> micePUFA |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
María Vinaixa Sandra Canelles África González-Murillo Vítor Ferreira Diana Grajales Santiago Guerra-Cantera Ana Campillo-Calatayud Manuel Ramírez-Orellana Óscar Yanes Laura M. Frago Ángela M. Valverde Vicente Barrios |
spellingShingle |
María Vinaixa Sandra Canelles África González-Murillo Vítor Ferreira Diana Grajales Santiago Guerra-Cantera Ana Campillo-Calatayud Manuel Ramírez-Orellana Óscar Yanes Laura M. Frago Ángela M. Valverde Vicente Barrios Increased Hypothalamic Anti-Inflammatory Mediators in Non-Diabetic Insulin Receptor Substrate 2-Deficient Mice Cells diabetes hypothalamus inflammation IRS2<sup>−/−</sup> mice PUFA |
author_facet |
María Vinaixa Sandra Canelles África González-Murillo Vítor Ferreira Diana Grajales Santiago Guerra-Cantera Ana Campillo-Calatayud Manuel Ramírez-Orellana Óscar Yanes Laura M. Frago Ángela M. Valverde Vicente Barrios |
author_sort |
María Vinaixa |
title |
Increased Hypothalamic Anti-Inflammatory Mediators in Non-Diabetic Insulin Receptor Substrate 2-Deficient Mice |
title_short |
Increased Hypothalamic Anti-Inflammatory Mediators in Non-Diabetic Insulin Receptor Substrate 2-Deficient Mice |
title_full |
Increased Hypothalamic Anti-Inflammatory Mediators in Non-Diabetic Insulin Receptor Substrate 2-Deficient Mice |
title_fullStr |
Increased Hypothalamic Anti-Inflammatory Mediators in Non-Diabetic Insulin Receptor Substrate 2-Deficient Mice |
title_full_unstemmed |
Increased Hypothalamic Anti-Inflammatory Mediators in Non-Diabetic Insulin Receptor Substrate 2-Deficient Mice |
title_sort |
increased hypothalamic anti-inflammatory mediators in non-diabetic insulin receptor substrate 2-deficient mice |
publisher |
MDPI AG |
series |
Cells |
issn |
2073-4409 |
publishDate |
2021-08-01 |
description |
Insulin receptor substrate (IRS) 2 is a key mediator of insulin signaling and IRS-2 knockout (IRS2<sup>−/−</sup>) mice are a preclinical model to study the development of diabetes, as they develop peripheral insulin resistance and beta-cell failure. The differential inflammatory profile and insulin signaling in the hypothalamus of non-diabetic (ND) and diabetic (D) IRS2<sup>−/−</sup> mice might be implicated in the onset of diabetes. Because the lipid profile is related to changes in inflammation and insulin sensitivity, we analyzed whether ND IRS2<sup>−/−</sup> mice presented a different hypothalamic fatty acid metabolism and lipid pattern than D IRS2<sup>−/−</sup> mice and the relationship with inflammation and markers of insulin sensitivity. ND IRS2<sup>−/−</sup> mice showed elevated hypothalamic anti-inflammatory cytokines, while D IRS2<sup>−/−</sup> mice displayed a proinflammatory profile. The increased activity of enzymes related to the pentose-phosphate route and lipid anabolism and elevated polyunsaturated fatty acid levels were found in the hypothalamus of ND IRS2<sup>−/−</sup> mice. Conversely, D IRS2<sup>−/−</sup> mice have no changes in fatty acid composition, but hypothalamic energy balance and markers related to anti-inflammatory and insulin-sensitizing properties were reduced. The data suggest that the concurrence of an anti-inflammatory profile, increased insulin sensitivity and polyunsaturated fatty acids content in the hypothalamus may slow down or delay the onset of diabetes. |
topic |
diabetes hypothalamus inflammation IRS2<sup>−/−</sup> mice PUFA |
url |
https://www.mdpi.com/2073-4409/10/8/2085 |
work_keys_str_mv |
AT mariavinaixa increasedhypothalamicantiinflammatorymediatorsinnondiabeticinsulinreceptorsubstrate2deficientmice AT sandracanelles increasedhypothalamicantiinflammatorymediatorsinnondiabeticinsulinreceptorsubstrate2deficientmice AT africagonzalezmurillo increasedhypothalamicantiinflammatorymediatorsinnondiabeticinsulinreceptorsubstrate2deficientmice AT vitorferreira increasedhypothalamicantiinflammatorymediatorsinnondiabeticinsulinreceptorsubstrate2deficientmice AT dianagrajales increasedhypothalamicantiinflammatorymediatorsinnondiabeticinsulinreceptorsubstrate2deficientmice AT santiagoguerracantera increasedhypothalamicantiinflammatorymediatorsinnondiabeticinsulinreceptorsubstrate2deficientmice AT anacampillocalatayud increasedhypothalamicantiinflammatorymediatorsinnondiabeticinsulinreceptorsubstrate2deficientmice AT manuelramirezorellana increasedhypothalamicantiinflammatorymediatorsinnondiabeticinsulinreceptorsubstrate2deficientmice AT oscaryanes increasedhypothalamicantiinflammatorymediatorsinnondiabeticinsulinreceptorsubstrate2deficientmice AT lauramfrago increasedhypothalamicantiinflammatorymediatorsinnondiabeticinsulinreceptorsubstrate2deficientmice AT angelamvalverde increasedhypothalamicantiinflammatorymediatorsinnondiabeticinsulinreceptorsubstrate2deficientmice AT vicentebarrios increasedhypothalamicantiinflammatorymediatorsinnondiabeticinsulinreceptorsubstrate2deficientmice |
_version_ |
1721194300120760320 |